Annovis Bio (ANVS) is scheduled to report Q1 earnings on May 15, 2026. Analysts estimate EPS of $-0.35 and quarterly revenue of N/A.
In the most recent quarter (Q4), Annovis Bio reported EPS of $-0.39, missing estimates of $-0.34 by 0.15%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Over the last 4 quarters, Annovis Bio has averaged an EPS surprise of 0.10% and a revenue surprise of 0.00%.
Analyze the earnings history of Annovis Bio using advanced sorting and filters.
The chart below shows Annovis Bio's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Annovis Bio's reported revenue compared to analyst estimates over recent quarters.
Annovis Bio (ANVS) is scheduled to report earnings on May 15, 2026. The last reported earnings were for reported on March 16, 2026 for Q4.
The Actual EPS was $-0.39, which missed the estimate of $-0.34.
The Actual Revenue was $0.00, which hit the estimate of $0.00.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-03-16 | $-0.39 | $-0.34 | -14.7 % |
| Q3 | 2025-11-12 | $-0.37 | $-0.37 | 0.00 % |
| Q2 | 2025-08-12 | $-0.32 | $-0.38 | 15.8 % |
| Q1 | 2025-05-13 | $-0.32 | $-0.29 | -10.3 % |